Koyfin Home > Directory > Health Care > Intra-Cellular Ther > EBITDA

Intra-Cellular Ther EBITDA Chart (ITCI)

Intra-Cellular Ther annual/quarterly EBITDA from 2012 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Intra-Cellular Ther EBITDA for the quarter ending June 06, 2020 was $-65m a 44.01% decrease of -28m year over year
  • Intra-Cellular Ther EBITDA for the last 12 months ending June 06, 2020 was $-192m a 19.38% decrease of -37m year over year
  • Intra-Cellular Ther Annual EBITDA for 2019 was $-154m a -5.45% increase of 8m from 2018
  • Intra-Cellular Ther Annual EBITDA for 2018 was $-162m a 36.61% decrease of -59m from 2017
  • Intra-Cellular Ther Annual EBITDA for 2017 was $-103m a -15.04% increase of 15m from 2016
Other Income Statement Metrics:
  • Intra-Cellular Ther Net Income for the quarter ending December 12, 2018 was $-41m a 12.93% decrease of -5m year over year
  • Intra-Cellular Ther Total Revenue for the quarter ending December 12, 2017 was $0m a -1,785.00% decrease of 0m year over year
View Chart On Koyfin

Quarterly ITCI EBITDA Data

06/2020$-65m
03/2020$-49m
12/2019$-42m
09/2019$-36m
06/2019$-39m
03/2019$-37m
12/2018$-43m
09/2018$-43m
06/2018$-39m
03/2018$-37m

Annual ITCI EBITDA Data

2019$-154m
2018$-162m
2017$-103m
2016$-118m
2015$-106m
2014$-31m
2013$-26m
2012$-16m
2011$11m